Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controls

European Journal of Cancer Prevention

Volumn 12, Issue 4, 2003, Pages 309-315

  Kaaks, R ^a   Lukanova, A ^a   Rinaldi, S ^a   Biessy, C ^a   Soderberg S ^b   Olsson, T ^b   Stenman, U H ^c   Riboli, E ^a   Hallmans, G ^d   Stattin, P ^b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UMEÅ UNIVERSITY   (Sweden)

Author keywords

IGF binding proteins 1, 2, 3, insulin, insulin like growth factor I (IGF I); Leptin; Prostate cancer risk; Sex hormone binding globulin; Testosterone

Indexed keywords

ANDROGEN; INSULIN; LEPTIN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TESTOSTERONE;

ANDROGEN BLOOD LEVEL; ARTICLE; BODY MASS; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TESTOSTERONE BLOOD LEVEL;

BODY MASS INDEX; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MALE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; SWEDEN; TESTOSTERONE;

EID: 12444253866     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200308000-00011     Document Type: Article

References (61)

1. Ahima RS, Flier JS (2000). Leptin. Annu Rev Physiol 62: 413-437.
2. Anderson DC, Thorner MO, Fisher RA, et al. (1975). Effects of hormonal treatment on plasma unbound androgen levels in hirsute women. Acta Endocrinol (Copenhagen) 199(Suppl): 224.
3. Bebakar WM, Honour JW, Foster D, et al. (1990). Regulation of testicular function by insulin and transforming growth factor-beta. Steroids 55: 266-270.
4. Benbassat CA, Maki KC, Unterman TG (1997). Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures. J Clin Endocrinol Metab 82: 1484-1491.
5. Bladou F, Vessela RL, Buhler KR, et al. (1996). Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castration. Int J Cancer 67: 785-790.
6. Bosland MC (1996). Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models. Prog Clin Biol Res 394: 309-352.
7. Bosland MC (2000). Chapter 2: The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr 27: 39-66.
8. Chan JM, Stampfer MJ, Giovannucci EL (1998a). What causes prostate cancer? A brief summary of the epidemiology. Semin Cancer Biol 8: 263-273.
9. Chan JM, Stampfer MJ, Giovannucci E, et al. (1998b). Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279: 563-566.
10. Chan JM, Stampfer MJ, Ma J, et al. (2002). Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 94: 1099-1106.
11. Chang S, Hursting SD, Contois JH, et al. (2001). Leptin and prostate cancer. Prostate 46: 62-67.
12. Chokkalingam AP, Pollak M, Fillmore CM, et al. (2001). Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev 10: 421-427.
13. De Mellow JS, Handelsman DJ, Baxter RC (1987). Short-term exposure to insulin-like growth factors stimulates testosterone production by testicular interstitial cells. Acta Endocrinol (Copenhagen) 115: 483-489.
14. Dunaif A (1999). Insulin action in the polycystic ovary syndrome. Endocrinol Metab Clin North Am 28: 341-359.
15. Eaton NE, Reeves GK, Appleby PN, et al. (1999). Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies. Br J Cancer 80: 930-934.
16. Erfurth EM, Hagmar LE, Saaf M, et al. (1996). Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein 1 correlate with serum free testosterone and sex hormone binding globulin levels in healthy young and middle-aged men. Clin Endocrinol (Oxford) 44: 659-664.
17. Falkner B, Sherif K, Sumner A, et al. (1999). Hyperinsulinism and sex hormones in young adult African Americans. Metabolism 48: 107-112.
18. Ferrini RL, Barrett-Connor E (1998). Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 147: 750-754.
19. Gann PH, Hennekens CH, Ma J, et al. (1996). Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 88: 1118-1126.
20. Giagulli VA, Kaufman JM, Vermeulen A (1994). Pathogenesis of the decreased androgen levels in obese men. J Clin Endocrinol Metab 79: 997-1000.
21. Grimberg A, Cohen P (2000). Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 183: 1-9.
22. Haffner SM, Karhapaa P, Mykkanen L et al. (1994a). Insulin resistance, body fat distribution, and sex hormones in men. Diabetes 43: 212-219.
23. Haffner SM, Valdez RA, Mykkanen L, et al. (1994b). Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men. Metabolism 43: 599-603.
24. Haffner SM, Shaten J, Stern MP et al. (1996). Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol 143: 889-897.
25. Harman SM, Metter EJ, Blackman MR, et al. (2000). Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. J Clin Endocrinol Metab 85: 4258-4265.
26. Hesse V, Jahreis G, Schambach H, et al. (1994). Insulin-like growth factor I correlations to changes of the hormonal status in puberty and age. Exp Clin Endocrinol 102: 289-298.
27. Hileman SM, Pierroz DD, Flier JS (2000). Leptin, nutrition, and reproduction: timing is everything. J Clin Endocrinol Metab 85: 804-807.
28. Hsing AW, Tsao L, Devesa SS (2000). International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 85: 60-67.
29. Hsing AW, Chua Jr S, Gao YT, et al. (2001). Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst 93: 783-789.
30. Isidori AM, Caprio M, Strollo F, et al. (1999). Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab 84: 3673-3680.
31. Janssen JA, Stolk RP, Pols HA et al. (1998). Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroid levels. Clin Endocrinol (Oxford) 48: 471-478.
32. Jones JI, Clemmons DR (1995). Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-34.
33. Juul A, Bang P, Hertel NT, et al. (1994). Serum insulin-like growth factor-I in 1030 healthy chldren, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78: 744-752.
34. Kaaks R, Lukanova A, Sommersberg B (2000). Plasma androgens, IGF-I, body size and prostate cancer risk: a synthetic review. Prostate Cancer Prostatic Dis 3: 157-172.
35. Kahn BB, Flier JS. (2000). Obesity and insulin resistance. J Clin Invest 106: 473-481.
36. Kyprianou N, English HF, Isaacs JT (1990). Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res 50: 3748-3753.
37. Lagiou P, Signorello LB, Trichopoulos D, et al. (1998). Leptin in relation to prostate cancer and benign prostatic hyperplasia. Int J Cancer 76: 25-28.
38. Lin T, Haskell J, Vinson N, et al. (1986). Direct stimulatory effects of insulin-like growth factor-I on Leydig cell steroidogenesis in primary culture. Biochem Biophys Res Commun 137: 950-956.
39. Lucia MS, Bostwick DG, Bosland M, et al. (1998). Workgroup I: rodent models of prostate cancer. Prostate 36: 49-55.
40. Nair B, Wilt T, MacDonald R, Rucks I (2002). Early versus deferred androgen suppression in the treatment of advanced prostatic cancer. Cochrance Database Syst Rev (1) CD003506.
41. Pasquali R, Casimirri F, Cantobelli S, et al. (1991). Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 40: 101-104.
42. Pfeilschifter J, Scheidt-Nave C, Leidig-Bruckner G, et al. (1996). Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women. J Clin Endocrinol Metab 81: 2534-2540.
43. Plymate SR, Hoop RC, Jones RE, et al. (1990). Regulation of sex hormone-binding globulin production by growth factors. Metabolism 39: 967-970.
44. Poretsky L, Cataldo NA, Rosenwaks Z, et al. (1999). The insulin-related ovarian regulatory system in health and disease. Endocr Rev 20: 535-582.
45. Rutanen EM, Karkkainen T, Stenman UH, et al. (1993). Aging is associated with decreased suppression of insulin-like growth factor binding protein-1 by insulin. J Clin Endocrinol Metab 77: 1152-1155.
46. SAS Institute Inc. (1989.) SAS/STAT User's Guide: Version 6, 4th edn. SAS Institute Inc., Cary, NC.
47. Singh A, Hamilton-Fairley D, Koistinen R, et al. (1990). Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells. J Endocrinol 124: R1-R3.
48. Spiteri-Grech J, Nieschlag E (1992). The role of growth hormone and insulin-like growth factor I in the regulation of male reproductive function. Horm Res 38(Suppl): 22-27.
49. Stattin P, Bylund A, Rinaldi S, et al. (2000). Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 92: 1910-1917.
50. Stattin P, Söderberg S, Hallmans G, et al. (2001). Leptin is associated with increased prostate cancer risk. A nested-case-referent study. J Clin Endocrinol Metab 86: 1341-1345.
51. Tchernof A, Despres JP, Dupont A et al. (1995). Relation of steroid hormones to glucose tolerance and plasma insulin levels in men. Importance of visceral adipose tissue. Diabetes Care 18: 292-299.
52. Thissen JP, Ketelslegers JM, Underwood LE (1994). Nutritional regulation of the insulin-like growth factors. Endocr Rev 15: 80-101.
53. Tibblin G, Adlerberth A, Lindstedt G, et al. (1996). The pituitary-gonadal axis and health in elderly men: a study of men born in 1913. Diabetes 45: 1605-1609.
54. Veldhuis JD, Urban RJ, Lizarralde G, et al. (1992). Attenuation of luteinizing hormone secretory burst amplitude as a proximate basis for the hypoandrogenism of healthy aging in men. J Clin Endocrinol Metab 75: 707-713.
55. Vermeulen A, Kaufman JM, Deslypere JP, et al. (1993). Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men. J Clin Endocrinol Metab 76: 1140-1146.
56. Vermeulen A, Kaufman JM, Giagulli VA (1996). Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 81: 1821-1826.
57. Vermeulen A, Goemaere S, Kaufman JM (1999a). Testosterone, body composition and aging. J Endocrinol Invest 22: 110-116.
58. Vermeulen A, Verdonck L, Kaufman JM (1999b). A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84: 3666-3672.
59. Wolk A, Mantzoros CS, Andersson SO, et al. (1998). Insulin-like growth factor I and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst 90: 911-915.
60. Wu AH, Whittemore AS, Kolonel LN, et al. (1995). Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev 4: 735-741.
61. Zumoff B, Strain GW, Miller LK, et al. (1990). Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. J Clin Endocrinol Metab 71: 929-931.